Tagraxofusp – API Insight, 2018
Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains [read full press release…]
pipeline analysis
Want to know positive clinical results of Akt/Protein Kinase B (PKB) Inhibitors?
CITY, Country, 2019-Jul-17 — /EPR Network/ — According to a new research report “Akt/Protein Kinase B (PKB) Inhibitors – Pipeline Analysis 2018, Clinical Trials & Results, Patents, [read full press release…]
